Patent Assignment
Reel/Frame 075652/0212
Release of Patent Security Agreement Recorded at Reel 067398 and Frame 0261
Recorded: 2026-05-15
Pages: 12
Assignor
SIXTH STREET LENDING PARTNERS, IN ITS CAPACITY AS ADMINISTRATIVE AGENT
Executed: 2026-05-14
Assignee
APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, THIRD FLOOR, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(45)
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Application:
18/133,372 →
Publication:
US US20240076317A1
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Application:
17/673,703 →
Publication:
US US20230091471A1
Dosing Regimens
Combination Therapy for C3 Inhibition
Application:
17/719,074 →
Publication:
US US20230009757A1
Dosing Regimens and Related Compositions and Methods
Application:
18/386,542 →
Publication:
US US20240285783A1
Dosing Regimens and Related Compositions and Methods
Viral Vector Therapy
Application:
17/624,755 →
Publication:
US US20220249706A1
Rnas for Complement Inhibition
Treatment of Paroxysmal Nocturnal Hemoglobinuria
Application:
17/791,194 →
Publication:
US US20230076527A1
Rnas for Complement Inhibition
Application:
17/798,339 →
Publication:
US US20230095695A1
Methods of Treating Eye Disorders
Application:
18/027,331 →
Publication:
US US20230381269A1
Genomic Editing of Complement
Application:
18/266,464 →
Publication:
US US20240110182A1
Polypeptides for Complement Inhibition
Application:
18/282,664 →
Publication:
US US20250145673A1
Genomic Editing of Complement
Application:
18/563,588 →
Publication:
US US20240216538A1
Treatment of Complement-Mediated Disorders
Application:
18/563,184 →
Publication:
US US20250002910A1
Complement Inhibition
Application:
18/573,634 →
Publication:
US US20240360103A1
Treatment of Geographic Atrophy
Application:
18/690,607 →
Publication:
US US20250000936A1
Systems and Methods for Virtual Reality, Augmented Reality, and Mixed Reality Based Visual Function Assessment
Application:
18/702,594 →
Publication:
US US20260157626A1
Complement Inhibition
Application:
63/580,696 →
Complement Inhibition
Application:
63/622,472 →
Methods of Using Geographic Atrophy Lesion Characteristics
Application:
63/588,224 →
C3 Targeted Inhibitory Rna
Application:
63/556,773 →
Compositions and Methods for Enhancing Phagocytosis or Phagocyte Activity
Methods of Treating Age-Related Macular Degeneration by Compstatin and Analogs Thereof
A method of treating age-related macular degeneration comprising administering a compstatin analog
Methods of Selecting Compstatin Mimetics
Local Complement Inhibition for Treatment of Complement-Mediated Disorders
Compstatin Analogs for Treatment of Neuropathic Pain
Compstatin Analogs for Treatment of Neuropathic Pain
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Methods of Treating Chronic Disorders with Complement Inhibitors
Methods of Treating Chronic Disorders with Complement Inhibitors
Methods of Treating Chronic Disorders with Complement Inhibitors
Detection of High Risk Drusen
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Dosing Regimens
Combination Therapy for C3 Inhibition
Dosing Regimens and Related Compositions and Methods
Dosing Regimens and Related Compositions and Methods
Rnas for Complement Inhibition
Patent:
11,510,939 →
Application:
16/853,732 →
Treatment of Geographic Atrophy
PCT:
PCT/US2022/043127 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 31, 2005
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL; OLSON, PAUL; MACHIELS, ALEC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 016205/0411 →
Assignment of Assignor's Interest
Jan 13, 2012
From: DESCHATELETS, PASCAL; OLSON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 027527/0010 →
Assignment of Assignor's Interest
May 28, 2013
From: DESCHATELETS, PASCAL; OSLON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 030495/0158 →
Corrective Assignment to Correct the Spelling of Paul Olson's Name Previously Recorded on Reel 030495 Frame 0158. Assignor(S) Hereby Confirms the Name Olson Was Incorrectly Spelled Oslon.
Jun 6, 2013
From: DESCHATELETS, PASCAL; OLSON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 030600/0956 →
Assignment of Assignor's Interest
Dec 2, 2015
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 037185/0575 →
Assignment of Assignor's Interest
Oct 21, 2020
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 054174/0173 →
Assignment of Assignor's Interest
Oct 21, 2020
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 054174/0194 →
Assignment of Assignor's Interest
Feb 18, 2022
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 059047/0373 →
Assignment of Assignor's Interest
Mar 23, 2022
From: FRANCOIS, CEDRIC; SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 059380/0875 →
Assignment of Assignor's Interest
Jul 11, 2022
From: FRANCOIS, CEDRIC
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 060471/0037 →
Assignment of Assignor's Interest
Sep 30, 2022
From: AXOLABS GMBH
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 061269/0476 →
Assignment of Assignor's Interest
Sep 30, 2022
From: HOSSBACH, MARKUS; HULTSCH, KATHRIN
To: AXOLABS GMBH
Reel/Frame 061269/0381 →
Assignment of Assignor's Interest
Mar 7, 2023
From: MUELLER, CHRISTIAN; SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 062906/0901 →
Assignment of Assignor's Interest
Apr 5, 2023
From: METLAPALLY, RAVIKANTH; RIBEIRO, RAMIRO MAGALHAES
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 063229/0855 →
Assignment of Assignor's Interest
Nov 10, 2023
From: GROSSI, FEDERICO; DESCHATELETS, PASCAL; FRANCOIS, CEDRIC; VEGA, CAROLINA
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065526/0282 →
Assignment of Assignor's Interest
Nov 10, 2023
From: JPHARMA SOLUTIONS GMBH
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065526/0340 →
Assignment of Assignor's Interest
Nov 10, 2023
From: JOHNSON, PATRICK
To: JPHARMA SOLUTIONS GMBH
Reel/Frame 065526/0323 →
Assignment of Assignor's Interest
Nov 10, 2023
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065523/0901 →
Assignment of Assignor's Interest
Nov 10, 2023
From: BARBOUR, TARA; DESCHATELETS, PASCAL; SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065525/0498 →
Assignment of Assignor's Interest
Mar 1, 2024
From: SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 066616/0221 →
Assignment of Assignor's Interest
Mar 13, 2024
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL; GROSSI, FREDERICO
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 066755/0176 →
Assignment of Assignor's Interest
Mar 20, 2024
From: GROSSI, FEDERICO; DESCHATELETS, PASCAL; FRANCOIS, CEDRIC
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 066834/0009 →
Security Interest
May 13, 2024
From: APELLIS PHARMACEUTICALS, INC.
To: SIXTH STREET LENDING PARTNERS
Reel/Frame 067398/0261 →
Assignment of Assignor's Interest
Jun 11, 2024
From: JOHNSON, PATRICK
To: JPHARMA SOLUTIONS GMBH
Reel/Frame 067691/0931 →
Assignment of Assignor's Interest
Jun 11, 2024
From: GROSSI, FEDERICO; DESCHATELETS, PASCAL; FRANCOIS, CEDRIC; VEGA, CAROLINA
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 067691/0916 →